Spirolactam tricyclic CGRP receptor antagonists

Details for Australian Patent Application No. 2006316642 (hide)

Owner Merck & Co., Inc.

Inventors Gallicchio, Steven N.; Theberge, Cory R.; Bell, Ian M.; Selnick, Harold G.; Stump, Craig A.; Zartman, C. Blair

Agent Spruson & Ferguson

Pub. Number AU-A-2006316642

PCT Pub. Number WO2007/061692

Priority 60/737,977 18.11.05 US

Filing date 14 November 2006

Wipo publication date 31 May 2007

International Classifications

A01N 35/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical

A61K 31/12 (2006.01) - Ketones

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/061692 Priority application(s): WO2007/061692

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316644-Spirohydantoin tricyclic CGRP receptor antagonists

2006316638-Accommodative intraocular lens